MSB 1.50% $1.35 mesoblast limited

Ann: Update on Novartis Agreement, page-280

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,402 Posts.
    lightbulb Created with Sketch. 1110
    Hi,
    At the moment the company has not told us why NVS have backed out.

    The company has said they are proceeding with the COVID ARDs trial.

    Iam amazed how many posters are hoping that MSB fail its quite astonishing.

    They are just trying to save people from agonising deaths.

    Iam not going to name names but it really is pathetic.

    As for me I still believe the science and indeed the outstanding trial results
    the company has had which are all independently compiled by experts in their field.

    What will be interesting is what happens if and when we get the thumbs up from OTAT.

    I mean with a 5 year track record and ever increasing sales in Japan
    just how can the FDA give us a knock back.

    If one of our resident geniuses did a forward projection looking at sales number for Japan
    that would interesting. Last time I looked sales were beginning to look promising.

    Bad day for us, better days ahead.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.35
Change
0.020(1.50%)
Mkt cap ! $1.541B
Open High Low Value Volume
$1.35 $1.40 $1.34 $3.562M 2.615M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.35
 

Sellers (Offers)

Price($) Vol. No.
$1.36 17969 2
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.